GRI Bio Announces 1-for-13 Reverse Stock Split Effective June 17, 2024
Portfolio Pulse from Benzinga Newsdesk
GRI Bio has announced a 1-for-13 reverse stock split effective June 17, 2024. The company aims to regain compliance with Nasdaq listing requirements. Trading on a split-adjusted basis will begin on June 18, 2024, under a new CUSIP.
June 14, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GRI Bio has announced a 1-for-13 reverse stock split to regain compliance with Nasdaq listing requirements. The split will be effective on June 17, 2024, with trading on a split-adjusted basis starting June 18, 2024.
The reverse stock split is a strategic move to regain compliance with Nasdaq listing requirements. While it does not change the company's market capitalization, it may affect investor perception and trading behavior in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100